Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of Posaconazole
Open Access
- 26 November 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 2017
Abstract
Co-precipitation is an emerging method to generate amorphous solid dispersions (ASDs), notable for its ability to enable the production of ASDs containing pharmaceuticals with thermal instability and limited solubility. As is true for spray drying and other unit operations to generate amorphous materials, changes in processing conditions during co-precipitation, such as solvent selection, can have a significant impact on the molecular and bulk powder properties of co-precipitated amorphous dispersions (cPAD). Using posaconazole as a model API, this work investigates how solvent selection can be leveraged to mitigate crystallization and maximize bulk density for precipitated amorphous dispersions. A precipitation process is developed to generate high-bulk-density amorphous dispersions. Insights from this system provide a mechanistic rationale to control the solid-state and bulk powder properties of amorphous dispersions.Keywords
This publication has 66 references indexed in Scilit:
- Fusion processing of itraconazole solid dispersions by kinetisol® dispersing: A comparative study to hot melt extrusionJournal of Pharmaceutical Sciences, 2010
- Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- A Model-Based Methodology for Spray-Drying Process DevelopmentJournal of Pharmaceutical Innovation, 2009
- Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologiesInternational Journal of Pharmaceutics, 2009
- Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An OverviewMolecular Pharmaceutics, 2008
- Application of Melt Extrusion in the Development of a Physically and Chemically Stable High-Energy Amorphous Solid Dispersion of a Poorly Water-Soluble DrugMolecular Pharmaceutics, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Supersaturation Produces High Bioavailability of Amorphous Danazol Particles Formed by Evaporative Precipitation into Aqueous Solution and Spray Freezing into Liquid TechnologiesDrug Development and Industrial Pharmacy, 2006
- PosaconazoleDrugs, 2005
- Pharmaceutical Applications of Solid Dispersion SystemsJournal of Pharmaceutical Sciences, 1971